BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36434154)

  • 21. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of
    Şahin OE; Uslu-Beşli L; Asa S; Sağer S; Sönmezoğlu K
    Hell J Nucl Med; 2020; 23(3):321-329. PubMed ID: 33367304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head-to-head comparison of
    Liu Q; Zang J; Yang Y; Ling Q; Wu H; Wang P; Lu L; Zhu Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4386-4395. PubMed ID: 34146130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]   [Full Text] [Related]  

  • 27. The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.
    Pouliot F; Beauregard JM; Saad F; Trudel D; Richard PO; Turcotte É; Rousseau É; Probst S; Kassouf W; Anidjar M; Camirand Lemyre F; Bouvet GF; Neveu B; Tétu A; Guérin B
    BJU Int; 2022 Sep; 130(3):314-322. PubMed ID: 34674367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on
    Zidan L; Iravani A; Kong G; Akhurst T; Michael M; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):204-216. PubMed ID: 32572559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparison of three different molecular imaging methods in localization and grading of insulinoma.
    Chang L; Bi X; Li S; Tong Q; Gu Y; He Z; Li Y; Chen Q; Cui J; Yu H; He Q; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1163176. PubMed ID: 37455905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of a three-scale grading system based on combining molecular imaging with
    Karfis I; Marin G; Levillain H; Drisis S; Muteganya R; Critchi G; Taraji-Schiltz L; Guix CA; Shaza L; Elbachiri M; Mans L; Machiels G; Hendlisz A; Flamen P
    Oncotarget; 2020 Feb; 11(6):589-599. PubMed ID: 32110279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine Learning-Based Noninvasive Quantification of Single-Imaging Session Dual-Tracer
    Ding W; Yu J; Zheng C; Fu P; Huang Q; Feng DD; Yang Z; Wahl RL; Zhou Y
    IEEE Trans Med Imaging; 2022 Feb; 41(2):347-359. PubMed ID: 34520350
    [No Abstract]   [Full Text] [Related]  

  • 33. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Bone Metastases by
    Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J
    Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of
    Nguyen A; Fullard K; Sheehan-Dare G; Tang R; Chan L; Ho B; Dear R; Keane J; Hickey A; Nandurkar R; Chen J; Chen A; Lim E; Emmett L
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):731-737. PubMed ID: 34676675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Atherosclerotic Inflammation by
    Tarkin JM; Joshi FR; Evans NR; Chowdhury MM; Figg NL; Shah AV; Starks LT; Martin-Garrido A; Manavaki R; Yu E; Kuc RE; Grassi L; Kreuzhuber R; Kostadima MA; Frontini M; Kirkpatrick PJ; Coughlin PA; Gopalan D; Fryer TD; Buscombe JR; Groves AM; Ouwehand WH; Bennett MR; Warburton EA; Davenport AP; Rudd JH
    J Am Coll Cardiol; 2017 Apr; 69(14):1774-1791. PubMed ID: 28385306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of peptide receptor radionuclide therapy (PRRT) with tandem isotopes - [90Y]Y/[177Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on [18F]FDG PET/CT qualification in Polish multicentre experience - do we need [18F]FDG PET/CT for qualification to PRRT?
    Zemczak A; Kołodziej M; Gut P; Królicki L; Kos-Kudła B; Kamiński G; Ruchała M; Pawlak D; Kunikowska J
    Endokrynol Pol; 2020; 71(3):240-248. PubMed ID: 32293704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT.
    Zahed H; Beauregard JM; Abikhzer G; Rush C; Probst S
    Clin Nucl Med; 2023 Jan; 48(1):e12-e15. PubMed ID: 36240803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Utility of Total
    Tirosh A; Papadakis GZ; Millo C; Hammoud D; Sadowski SM; Herscovitch P; Pacak K; Marx SJ; Yang L; Nockel P; Shell J; Green P; Keutgen XM; Patel D; Nilubol N; Kebebew E
    Gastroenterology; 2018 Mar; 154(4):998-1008.e1. PubMed ID: 29155309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.